Aguilar M.I., Hart S.J., Calder I.C. Complete separation of urinary metabolites of paracetamol and substituted Paracetamols by reversed-phase ion-pair high-performance liquid chromatography. J. Chromatogr. 1988;426:315–333. [PubMed: 3392144]
Ameer B., Greenblatt D.J. Acetaminophen. Ann. intern. Med. 1977;87:202–209. [PubMed: 329728]
American Medical Association (1986) AMA Drug Evaluations, 6th ed., Philadelphia, W.B. Saunders, pp. 73–74.
Amo H., Matsuyama M. Subchronic and chronic effects of feeding of large amounts of acetaminophen in B6C3F1 mice. Jpn. J. Hyg. 1985;40:567–574. [PubMed: 4057664]
Apoteksbolaget (1988) Svensk Lälemedelsstatistik [Swedish Drugs Statistics], Stockholm, Pharmaceutical Association of Sweden.
Apoteksbolaget (1989) Outprint of the Drug Data Base (17 October 1989), Stockholm, The Pharmaceutical Association of Sweden.
Aselton P., Jick H., Milunsky A., Hunter J.R., Stergachis A. First trimester drug use and congenital disorders. Obstet. Gynecol. 1985;65:451–455. [PubMed: 3982720]
Barnhart, E. (1989) Physicians' Desk Reference, 43rd ed., Oradell, NJ, Medical Economics, p. 301.
Berlin C.M. Jr, Yaffe S.J., Ragni M. Disposition of acetaminophen in milk, saliva, and plasma of lactating women. Pediatr. Pharmacol. 1980;1:135–141. [PubMed: 7202185]
Betowski L.D., Korfmacher W.A., Lay J.O. Jr, Potter D.W., Hinson J.A. Direct analysis of rat bile for acetaminophen and two of its conjugated metabolites via thermospray liquid chromatography/mass spectrometry. Biomed. environ. mass Spectrom. 1987;14:705–709. [PubMed: 3435792]
Biemer T.A. Simultaneous analysis of acetaminophen, pseudoephedrine hydrochloride and chlorpheniramine maleate in a cold tablet using an isocratic, mixed micellar high-performance liquid chromatographic mobile phase. J. Chromatogr. 1987;410:206–210. [PubMed: 3429552]
Birge R.B., Bartolone J.B., Nishanian E.V., Bruno M.K., Mangold J.B., Cohen S.D., Khairallah E.A. Dissociation of covalent binding from the oxidative effects of acetaminophen. Biochem. Pharmacol. 1988;37:3383–3393. [PubMed: 3421990]
Black M. Acetaminophen hepatotoxicity. Ann. Rev. Med. 1984;35:577–593. [PubMed: 6372672]
Boyd E.M., Bereczky G.M. Liver necrosis from paracetamol. Br. J. Pharmacol. Chemother. 1966;26:606–614. [PMC free article: PMC1510721] [PubMed: 5959211]
Boyd E.M., Hogan S.E. The chronic oral toxicity of paracetamol at the range of the LD50 (100 days) in albino rats. Can. J. Physiol. Pharmacol. 1968;46:239–245. [PubMed: 5690725]
Carpenter H.M., Mudge G.H. Acetaminophen nephrotoxicity: studies on renal acetylation and deacetylation. J. Pharmacol. exp. Ther. 1981;218:161–167. [PubMed: 7241376]
Chemical Information Services Ltd (1989–90) Directory of World Chemical Producers, Oceanside, NY.
Clements J.A., Heading R.C., Nimmo W.S., Prescott L.F. Kinetics of acetaminophen absorption and gastric emptying in man. Clin. Pharmacol. Ther. 1978;24:420–431. [PubMed: 688732]
Collins E. Maternal and fetal effects of acetaminophen and salicylates in pregnancy. Obstet. Gynaecol. 1981;58 (Suppl. 5):57s–62s. [PubMed: 7031542]
Corcoran G.B., Mitchell J.R., Vaishnav Y.N., Horning E.C. Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-para-benzoqumoneimine. Mol. Pharmacol. 1980;18:536–542. [PubMed: 7464816]
Critchley J.A.J.H., Nimmo G.R., Gregson C.A., Woolhouse N.M., Prescott L.F. Inter-subject and ethnic differences in paracetamol metabolism. Br. J. clin. Pharmacol. 1986;22:649–657. [PMC free article: PMC1401198] [PubMed: 3567011]
Crombie D.L., Pinsent R.J.F.H., Slater B.C., Fleming D., Cross K.W. Teratogenic drugs. RCGP survey. Br. med. J. 1970;iv:178–179. [PMC free article: PMC1819922] [PubMed: 5475836]
Davidson D.G.D., Eastham W.N. Acute liver necrosis following overdose of paracetamol. Br. med. J. 1966;ii:497–499. [PMC free article: PMC1943529] [PubMed: 5913083]
Davis D.C., Potter W.Z., Jollow D.J., Mitchell J.R. Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen. Life Sci. 1974;14:2099–2109. [PubMed: 4847802]
Davis M., Harrison N.G., Ideo G., Portman B., Labadarios D., Williams R. Paracetamol metabolism in the rat: relationship to covalent binding and hepatic damage. Xenobiotica. 1976;6:249–255. [PubMed: 936645]
De Vries J. Hepatotoxic metabolic activation of paracetamol and its derivatives phenacetin and benorilate: oxygenation or electron transfer? Biochem. Pharmacol. 1981;30:399–402. [PubMed: 6112004]
Dixon M.F., Nimmo J., Prescott L.F. Experimental paracetamol-induced hepatic necrosis: a histopathological study. J. Pathol. 1971;103:225–229. [PubMed: 5563876]
Dunn T.L., Gardiner R.A., Seymour G.J., Lavin M.F. Genotoxicity of analgesic compounds assessed by an in vitro micronucleus assay. Mutat. Res. 1987;189:299–306. [PubMed: 3670333]
Dybing E., Holme J.A., Gordon W.P., Soderlund E.J., Dahlin D.C., Nelson S.D. Genotoxicity studies with paracetamol. Mutat. Res. 1984;138:21–32. [PubMed: 6387477]
El-Obeid H.A., Al-Badr A.A. Acetaminophen. Anal. Profiles Drug Subst. 1985;14:552–5.
Fairbrother J.E. Acetaminophen. Anal. Profiles Drug Subst. 1974;3:2–109.
Flaks A., Flaks B. Induction of liver cell tumours in IF mice by paracetamol. Carcinogenesis. 1983;4:363–368. [PubMed: 6839410]
Flaks B., Flaks A., Shaw A.P.W. Induction by paracetamol of bladder and liver tumours in the rat. Acta pathol. microbiol. immunol. scand. Sect. A. 1985;93:367–377. [PubMed: 4090988]
Flower, R.J., Moncada, S. & Vane, J.R. (1985) Analgesic-antipyretics and anti-inflammatory agents; drugs employed in the treatment of gout. In: oilman, AG., Goodman, L.S., Rall, T.W. & Murad, F., eds, Goodman and Gilman's The Pharmacological Basis of Therapeutics, 7th ed., New York, MacMillan, pp. 674–715.
Forrest J.A.H., Clements J.A., Prescott L.F. Clinical pharmacokinetics of paracetamol. Clin. Pharmacokinet. 1982;7:93–107. [PubMed: 7039926]
Friedman G.D., Ury H.K. Initial screening for carcinogenicity of commonly used drugs. J. natl Cancer Inst. 1980;65:723–733. [PubMed: 6932525]
Friedman G.D., Ury H.K. Screening for possible drug carcinogenicity: second report of findings. J. natl Cancer Inst. 1983;71:1165–1175. [PubMed: 6581357]
Galinsky R.E., Levy G. Dose and time-dependent elimination of acetaminophen in rats: pharmacokinetic implications of cosubstrate depletion. J. Pharmacol. exp. Ther. 1981;219:14–20. [PubMed: 7288602]
Gazzard B.G., Ford-Hutchinson A.W., Smith M.J.H., Williams R. The binding of paracetamol to plasma proteins of man and pig. J. Pharm. Pharmacol. 1973;25:964–967. [PubMed: 4150300]
Gemborys M.W., Mudge G.H. Formation and disposition of the minor metabolites of acetaminophen in the hamster. Drug Metab. Dispos. 1981;9:340–351. [PubMed: 6114834]
Gregus Z., Madhu C., Klaassen C.D. Species variation in tcxication and detoxication of acetaminophen in vivo: a comparative study of biliary and urinary excretion of acetaminophen metabolites. J. Pharmacol. exp. Ther. 1988;244:91–99. [PubMed: 3336012]
Gwilt J.R., Robertson A., McChaney E.W. Determination of blood and other tissue concentrations of paracetamol in dog and man. J. Pharm. Pharmacol. 1963;15:440–444. [PubMed: 13951545]
Hagiwara A., Ward J.M. The chronic hepatotoxic, tumor-promoting, and carcinogenic effects of acetaminophen in male B6C3F mice. Fundam. appl. Toxicol. 1986;7:376–386. [PubMed: 3781128]
Ham K.N., Calder I.C. Tumor formation induced by phenacetin and its metabolites. Adv. Inflammation Res. 1984;6:139–148.
Hamlyn A.N., Douglas A.P., James O.F.W., Lesna M., Watson A.J. Liver function and structure in survivors of acetaminophen poisoning: a follow-up of serum bile acids and liver histology. Am. J. dig. Dis. 1977;22:605–610. [PubMed: 879126]
Hasegawa R., Furukawa F., Toyoda K., Jang J.J., Yamashita K., Sato S., Takahashi M., Hayashi Y. Study for tumor-initiating effect of acetaminophen in two-stage liver carcinogenesis of male F344 rats. Carcinogenesis. 1988;9:755–759. [PubMed: 3365836]
Heinonen, O.P., Slone, D. & Shapiro, S. (1977) Birth Defects and Drugs in Pregnancy, Littleton, MA, Publishing Sciences Group, pp. 286–295.
Henry M.A., Tange J.D. Chronic renal lesions in the uninephrectomized Gunn rat after analgesic mixtures. Pathology. 1984;16:278–284. [PubMed: 6514396]
Hinson J.A., Nelson S.D., Mitchell J.R. Studies on the microsomal formation of arylating metabolites of acetaminophen and phenacetin. Mol. Pharmacol. 1977;13:625–633. [PubMed: 18660]
Hiraga K., Fujii T. Carcinogenicity testing of acetaminophen in F344 rats. Jpn. J. Cancer Res. (Gann). 1985;76:79–85. [PubMed: 3920105]
Hjelle J.J., Klaassen C.D. Glucuronidation and biliary excretion of acetaminophen in rats. J. Pharmacol. exp. Ther. 1984;228:407–413. [PubMed: 6694118]
Holme J.A., Soderlund E. Species differences in cytotoxic and genotoxic effects of phenacetin and paracetamol in primary monolayer cultures of hepatocytes. Mutat. Res. 1986;164:167–175. [PubMed: 3713718]
Holme J.A., Hongslo J.K., Bjornstad C., Harvison P.J., Nelson S.D. Toxic effects of paracetamol and related structures in V79 Chinese hamster cells. Mutagenesis. 1988;3:51–56. [PubMed: 3282144]
Hongslo J.K., Christensen T., Brunborg G., Bjornstad C., Holme J.A. Genotoxic effects of paracetamol in V79 Chinese hamster cells. Mutat. Res. 1988;204:333–341. [PubMed: 3343983]
IARC (1975) IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man, Vol. 8, Some Aromatic Azo Compounds, Lyon, pp. 75–81.
IARC (1977) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Vol. 15, Some Fumigants, the Herbicides 2,4-D and 2,4,5-T, Chlorinated Dibenzodioxins and Miscellaneous Industrial Chemicals, Lyon, pp. 255–264. [PubMed: 330387]
IARC (1980) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 24, Some Pharmaceutical Drugs, Lyon, pp. 135–161. [PubMed: 7009389]
IARC (1987) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Suppl. 7, Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42, pp. 310–312. [PubMed: 3482203]
Imamura A., Kurumi T., Danzuka T., Kodama M., Kawachi T., Nagao M. Classification of compounds by cluster analysis of Ames test data. Gann. 1983;74:196–204. [PubMed: 6345254]
Ishidate, M., Jr (1988) Data Book of Chromosomal Aberration Test In Vitro, rev. ed., Amsterdam, Elsevier.
Ishidate M. Jr., Hayashi M., Sawada M., Matsuoka A., Yoshikawa K., Ono M., Nakadate M. Cytotoxicity test on medical drugs—chromosome aberration tests with Chinese hamster cells in vitro. Bull. natl Inst. Hyg. Sci. (Tokyo). 1978;96:55–61. [PubMed: 750044]
Jacqueson A., Semont H., Thevenin M., Warnet J.M., Prost R., Claude J.R. Effects of daily high doses of paracetamol given orally during spermatogenesis in the rat testes. Arch. Toxicol., Suppl. 1984;7:164–166. [PubMed: 6595979]
James O., Lesna M., Roberts S.H., Pulman L., Douglas A.P., Smith P.A., Watson A.J. Liver damage after paracetamol overdose: comparison of liver function tests, fasting serum bile acids, and liver histology. Lancet. 1975;ii:579–581. [PubMed: 51407]
Jasiewicz M.L., Richardson J.C. Absence of mutagenic activity of benorylate, paracetamol and aspirin in the Salmonella/mammalian microsome test. Mutat. Res. 1987;190:95–100. [PubMed: 2881204]
Jick H., Holmes L.B., Hunter J.R., Madsen S., Stergachis A. First trimester drug use and congenital disorders. J. Am. med. Assoc. 1981;246:343–346. [PubMed: 7241780]
Johansson S.L. Carcinogenicity of analgesics: long-term treatment of Sprague-Dawley rats with phenacetin, phenazone, caffeine and paracetamol (acetamidophen). Int. J. Cancer. 1981;27:521–529. [PubMed: 7275356]
Jollow D.J., Thorgeirsson S.S., Potter W.Z., Hashimoto M., Mitchell J.R. Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Pharmacology. 1974;12:251–271. [PubMed: 4449889]
Kaysen G.A., Pond S.M., Roper M.H., Menki D.J., Marrama M.A. Combined hepatic and renal injury in alcoholics during therapeutic use of acetaminophen. Arch. intern. Med. 1985;145:2019–2023. [PubMed: 4062453]
King M.-T., Beikirch H., Eckhardt K., Gocke F., Wild D. Mutagenicity studies with X-ray-contrast media, analgesics, antipyretics, antirheumatics and some other pharmaceutical drugs in bacterial, Drosophila and mammalian test systems. Mutat. Res. 1979;66:33–43. [PubMed: 106272]
Kinney C.D., Kelly J.G. Liquid chromatographic determination of paracetamol and dextropropoxyphene in plasma. J. Chromatogr. 1987;419:433–437. [PubMed: 3667804]
Koch-Weser J. Drug therapy: acetaminophen. New Engl. J. Med. 1976;295:1297–1300. [PubMed: 790189]
Kocisova J., Rossner P., Binkova B., Bavorova H., Sram R.J. Mutagenicity studies on paracetamol in human volunteers. I. Cytogenetic analysis of peripheral lymphocytes and lipid peroxidation in plasma. Mutat. Res. 1988;209:161–165. [PubMed: 3193979]
Koizumi F., Kawamura T., Ishimori A., Ebina H., Satoh M. Plasma paracetamol concentrations measured by fluorescence polarization immunoassay and gastric emptying time. Tohoku J. exp. Med. 1988;155:159–164. [PubMed: 3062844]
Kurata Y., Asamoto M., Hagiwara A., Masui T., Fukushima S. Promoting effects of various agents in rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine. Cancer Lett. 1986;32:125–135. [PubMed: 3756839]
Lowenthal D.T., Oie S., Van Stone J.C., Briggs W.A., Levy G. Pharmacokinetics of acetaminophen elimination by anephric patients. J. Pharmacol. exp. Ther. 1976;196:570–578. [PubMed: 1263112]
Lubawy W.C., Burriss Garrett R.J. Effects of aspirin and acetaminophen on fetal and placental growth in rats. J. pharm. Sci. 1977;66:111–113. [PubMed: 833724]
Manno B.R., Manno J.E., Dempsey C.A., Wood M.A. A high-pressure liquid chromatographic method for the determination of N -acetyl-p-aminophenol (acetaminophen) in serum or plasma using a direct injection technique. J. anal. Toxicol. 1981;5:24–28. [PubMed: 7218775]
Maruyama H., Williams G.M. Hepatotoxicity of chronic high dose administration of acetaminophen to mice. A critical review and implications for hazard assessment. Arch. Toxicol. 1988;62:465–469. [PubMed: 3250377]
McCredie M., Stewart J.H. Does paracetamol cause urothelial cancer or renal papillary necrosis? Nephron. 1988;49:296–300. [PubMed: 3412544]
McCredie M., Stewart J., Ford J., MacLennan R. Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women. Br. J. Urol. 1983a;55:220–224. [PubMed: 6839099]
McCredie M., Stewart J., Ford J. Analgesics and tobacco as risk factors for cancer of the ureter and renal pelvis. J. Urol. 1983b;130:28–30. [PubMed: 6864908]
McCredie M., Ford J.M., Stewart J.H. Risk factors for cancer of the renal parenchyma. Int. J. Cancer. 1988;42:13–16. [PubMed: 3391702]
McLaughlin J.K., Blot W.J., Mandel J.S., Schuman L.M., Mehl E.S., Fraumeni J.F. Jr. Etiology of cancer of the renal pelvis. J. natl Cancer Inst. 1983;71:287–291. [PubMed: 6576188]
McLaughlin J.K., Mandel J.S., Blot W.J., Schuman L.M., Mehl E.S., Fraumeni J.F. Jr. A population-based case-control study of renal cell carcinoma. J. natl Cancer Inst. 1984;72:275–284. [PubMed: 6582315]
McLaughlin J.K., Blot W.J., Mehl E.S., Mandel J.S., Schuman L.M., Fraumeni J.F. Jr. Relation of analgesic use to renal cancer: population-based findings. Natl Cancer Inst. Monogr. 1985;69:217–222. [PubMed: 3834336]
McLean A.E.M., Armstrong A.R., Beales D. Effect of D- or L-methionine and cysteine on the growth inhibitory effects of feeding 1% paracetamol to rats. Biochem. Pharmacol. 1989;38:347–352. [PubMed: 2914020]
McMurty R.J., Snodgrass W.R., Mitchell J.R. Renal necrosis, glutathione depletion and covalent binding after acetaminophen. Toxicol. appl. Pharmacol. 1978;46:87–100. [PubMed: 725953]
Meatherall R., Ford D. Isocratic liquid chromatographic determination of theophylline, acetaminophen, chloramphenicol, caffeine, anticonvulsants, and barbiturates in serum. Ther. Drug Monit. 1988;10:101–115. [PubMed: 3376176]
Milam K.M., Byard J.L. Acetaminophen metabolism, cytotoxicity, and genotoxicity in rat primary hepatocyte cultures. Toxicol. appl. Pharmacol. 1985;79:342–347. [PubMed: 3923657]
Miner D.J., Kissenger P.T.1979Evidence for the involvement of N-acetyl-p-quinoneimine in paracetamol metabolism.Biochem. Pharmacol. 2832853290. [PubMed: 526335]
Mitchell J.R., Jollow D.J., Potter W.Z., Davis D.C., Gillette J.R., Brodie B.B. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol. exp. Ther. 1973;187:185–194. [PubMed: 4746326]
Mitchell J.R., Thorgeirsson S.S., Potter W.Z., Jollow D.J., Keiser H. Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin. Pharmacol. Ther. 1974;16:676–684. [PubMed: 4417718]
Moore M., Thor H., Moore G., Nelson S., Moldeus P., Orrenius S. The toxicity of acetaminophen and N-acetyl-p-benzoquinoneimine in isolated hepatocytes is associated with thiol depletion and increased cytosolic Ca2+. J. biol. Chem. 1985;260:13035–13039. [PubMed: 2932433]
Morris M.E., Levy G. Renal clearance and serum protein binding of acetaminophen and its major conjugates in humans. J. pharm. Sci. 1984;73:1038–1041. [PubMed: 6491906]
Nelson M.M., Forfar J.O. Association between drugs administered during pregnancy and congenital abnormalities of the fetus. Br. med. J. 1971;i:523–527. [PMC free article: PMC1795296] [PubMed: 4396080]
Nelson S.D., Dahlin D.C., Rauckman E.J., Rosen G.M. Peroxidase-mediated formation of reactive metabolites of acetaminophen. Mol. Pharmacol. 1981;20:195–199. [PubMed: 7290084]
Newton J.F., Kuo C.-H., Gemborys M.W., Mudge G.H., Hook J.B. Nephrotoxicity of p-aminophenol, a metabolite of acetaminophen, in the Fischer 344 rat. Toxicol. appl. Pharmacol. 1982;65:336–344. [PubMed: 7179289]
Newton J.F., Pasino D.A., Hook J.B. Acetaminophen nephrotoxicity in the rat: quantitation of renal metabolic activation in vivo. Toxicol. appl. Pharmacol. 1985;78:39–46. [PubMed: 4035671]
Notarianni L.J., Oldham H.G., Bennet P.N.1987Passage of paracetamol into breast milk and its subsequent metabolism be the neonate.Br. J. clin. Pharmacol. 246367. [PMC free article: PMC1386281] [PubMed: 3620287]
Oldham J.W., Preston R.F., Paulson J.D. Mutagenicity testing of selected analgesics in Ames Salmonella strains. J. appl. Toxicol. 1986;6:237–243. [PubMed: 3531298]
Patierno S.R., Lehman N.L., Henderson B.E., Landolph J.R. Study of the ability of phenacetin, acetaminophen, and aspirin to induce cytotoxicity, mutation, and morphological transformation in C3H/10T½ clone 8 mouse embryo cells. Cancer Res. 1989;49:1038–1044. [PubMed: 2912548]
Piper J.M., Tonascia J., Matanoski G.M. Heavy phenacetin use and bladder cancer in women aged 20 to 49 years. New Engl. J. Med. 1985;313:292–295. [PubMed: 4010740]
Placke M.E., Wyand D.S., Cohen S.D. Extrahepatic lesions induced by acetaminophen in the mouse. Toxicol. Pathol. 1987;15:381–383. [PubMed: 3432938]
Potter W.Z., Davis D.C., Mitchell H.R., Jollow D.G., Gillette J.R., Brodie B.B. Acetaminophen-induced hepatic necrosis. III. Cytochrome P-450-mediated covalent binding in vitro. J. Pharmacol. exp. Ther. 1973;187:203–209. [PubMed: 4147720]
Rawlings M.D., Henderson D.B., Hijab A.R. Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration. Eur. J. clin. Pharmacol. 1977;11:283–286. [PubMed: 862649]
Reddy G.A. Effects of paracetamol on chromosomes of bone marrow. Caryologia. 1984;37:127–132.
Reddy, G.A. & Subramanyam, S. (1981) Response of mitotic cells of Allium cepa to paracetamol. In: Manna, G.K. & Sinha, U., eds, Perspectives in Cytology and Genetics, Vol. 3, Delhi, Hindasi Publishers, pp. 571–576.
Reddy G.A., Subramanyam S. Cytogenetic response of meiocytes of Swiss albino mice to paracetamol. Caryologia. 1985;38:347–355.
Reicks M., Calvert R.J., Hathcock J.N. Effects of prolonged acetaminophen ingestion and dietary methionine on mouse liver glutathione. Drug-Nutr. Interact. 1988;5:351–363. [PubMed: 3240715]
Reynolds, J.E.F., ed. (1989) Martindale. The Extra Pharmacopoeia, 29th ed., London, The Pharmaceutical Press, pp. 32–34.
Ross R.K., Paganini-Hill A., Landolph J., Gerkins V., Henderson B.E. Analgesics, cigarette smoking and other risk factors for cancer of the renal pelvis and ureter. Cancer Res. 1989;49:1045–1048. [PubMed: 2912549]
Sasaki M. Enhancing effect of acetaminophen on mutagenesis. Prog. clin. biol. Res. 1986;209A:365–372. [PubMed: 3749056]
Sasaki M., Sugimura K., Yoshida M.A., Abe S. Cytogenetic effects of 60 chemicals on cultured human and Chinese hamster cells. Kromosomo. 1980;II-20:574–584.
Savides M.C., Oehme F.W., Nash S.L., Leipold H.W. The toxicity and biotransformation of single doses of acetaminophen in dogs and cats. Toxicol. appl. Pharmacol. 1984;74:26–34. [PubMed: 6729821]
Sawada M., Matsuoka A., Nohmi T., Sofuni T., Ishidate M. Jr. Mutagenicity tests on phenacetin-related compounds in cultured mammalian cells (Abstract). Mutat. Res. 1985;147:273.
Selby J.V., Friedman G.D., Fireman B.H. Screening prescription drugs for possible carcinogenicity: 11 to 15 years of follow-up. Cancer Res. 1989;49:5736–5747. [PubMed: 2571410]
Siegers C.-P., Strublet O., Schutt A. Relations between hepatotoxicity and pharmacokinetics of paracetamol in rats and mice. Pharmacology. 1978;16:273–278. [PubMed: 643897]
Tamura T., Fijii A., Kuboyama N. Pharmacological studies on the mutagenicity: I. Analgesics and antiinflammatory drugs and their derivatives. Jpn. J. Pharmacol. 1980;30 (Suppl.):238P.
Tsokos-Kuhn J.O., Hughes H., Smith C.V., Mitchell J.R. Alkylation of the liver plasma membrane and inhibition of the Ca2+ ATPase by acetaminophen. Biochem. Pharmacol. 1988;37:2125–2131. [PubMed: 2967703]
Tsuda H., Sakata T., Masui T., Imaida K., Ito N. Modifying effects of butylated hydroxyanisole, ethoxyquin and acetaminophen on induction of neoplastic lesions in rat liver and kidney initiated by N-ethyl-N-hydroxyethylnitrosamine. Carcinogenesis. 1984;5:525–531. [PubMed: 6142774]
Tsuruzaki T., Yamamoto M., Watanabe G. Maternal consumption of antipyretic analgesics produces chromosome anomalies in F1 rat embryos. Teratology. 1982;26:42A.
US Pharmacopeial Convention, Inc. (1989) US Pharmacopeia, 22nd rev., Easton, PA, pp. 12–15.
Watanabe M. The cytogenetic effects of aspirin and acetaminophen on in vitro human lymphocytes. Jpn. J. Hyg. 1982;37:673–685.
Weisburger J.H., Weisburger E.K., Madison R.M., Wenk M.L., Klein D.S. Effect of acetanilide and p-hydroxy-acetanilide on the carcinogenicity of N-2-fluoronylacetamide and N-hydroxy-N-2-fluorenylacetamide in mice, hamsters and female rats. J. natl Cancer Inst. 1973;51:235–240. [PubMed: 4720874]
Williams G.M., Mori H., McQueen C.A. Structure-activity relationship in the rat hepatocyte DNA repair test for 300 chemicals. Mutat. Res. 1989;221:263–286. [PubMed: 2682231]
Wirth P.J., Dybing E., von Bahr C., Thorgeirsson S.S. Mechanism of N-hydroxyacetylarylamine mutagenicity in the Salmonella test system: metabolic activation of N-hydroxyphenacetin by liver and kidney fractions from rat, mouse, hamster, and man. Mol. Pharmacol. 1980;18:117–127. [PubMed: 6997726]
Wong L.T., Solomonraj G., Thomas B.H. Metabolism of [14C]paracetamol and its interactions with aspirin in hamsters. Xenobiotica. 1976;6:575–584. [PubMed: 983128]
Wright N., Prescott L.F. Potentiation by previous drug therapy of hepatotoxicity following paracetamol overdosage. Scott. med. J. 1973;18:56–58. [PubMed: 4699828]
